Pre-market
Loading markets…

Advertisement

Stocks/TSX/RVX

Resverlogix Corp. (RVX : TSX)

Common Stock

$0.07

CAD

-0.01 (-6.25%)

Last updated: 2026-10-27

Follow RVX

RVX

Resverlogix Corp.

Source:WealthAwesomeWealthAwesome
↓ $0.01 (-16.67%)
30 day period
$0.07$0.09$0.10Sep 14Oct 6Oct 27

Performance

1 Day

-6.25%

1 Week

-6.25%

1 Month

-28.57%

YTD

-25.00%

Key Statistics

Market Cap

$25.82M

52W High

$0.15

52W Low

$0.07

P/E Ratio

-

50 Day MA

$0.09

200 Day MA

$0.10

Beta

1.06

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/27/2026$0.07$0.07$0.07$0.07$0.073,000
10/26/2026$0.08$0.08$0.08$0.08$0.0850,178
10/23/2026$0.09$0.09$0.09$0.09$0.090
10/22/2026$0.09$0.09$0.09$0.09$0.0923,300
10/21/2026$0.08$0.08$0.08$0.08$0.0848,000
10/20/2026$0.09$0.09$0.08$0.08$0.085,000
10/19/2026$0.09$0.09$0.09$0.09$0.093,000
10/16/2026$0.09$0.09$0.08$0.08$0.0863,264
10/15/2026$0.09$0.09$0.09$0.09$0.093,000
10/14/2026$0.09$0.09$0.09$0.09$0.093,470

Analyst Price Targets

Based on analyst covering RVX · as of Sep 17, 2026

📈

Wall Street analysts forecast RVX stock price to rise 10166.7% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$7.70

+10166.7% Upside

Current Price

C$0.07

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on RVX's historical volatility

HistoricalForecast68%95%
C$0.02C$0.05C$0.08C$0.12C$0.15C$0.18TodayJun 17Aug 21Oct 27Dec 9Jan 22Mar 6

30-Day Vol

84.9%

Annualized

90-Day Vol

80.9%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.06

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.07C$0.05 – C$0.09
60 trading daysC$0.07C$0.04 – C$0.10
90 trading daysC$0.06C$0.04 – C$0.10

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Resverlogix Corp.

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-4.77M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
-0.04
Book Value
-0.38

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About RVX

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
SLTSaltire Capital Ltd.$2.50+25.00%
BNGBengal Energy Ltd$0.03+20.00%
ARNAsarian Energy Limited$0.43+17.81%
EGLXEnthusiast Gaming Holdings Inc$0.04+16.67%
XNDUXanadu Quantum Technologies Limited$4.13+15.36%
SLRSolitario Exploration & Royalty Corp$0.74+12.12%
CLSCelestica Inc.$388.33+11.92%
LAMLaramide Resources Ltd.$0.48+11.63%

RVX.TO news timeline

15 articles covering RVX.TO, most recent first

Latest

What's Going On With Resverlogix Corp. Stock Thursday?

•Stocks

Advertisement